NDC 68547-005

Giapreza

Angiotensin Ii

Giapreza is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by La Jolla Pharmaceutical Company. The primary component is Angiotensin Ii.

Product ID68547-005_e235f25b-7a71-d6c3-e053-2995a90aa2a4
NDC68547-005
Product TypeHuman Prescription Drug
Proprietary NameGiapreza
Generic NameAngiotensin Ii
Dosage FormInjection
Route of AdministrationINTRAVENOUS
Marketing Start Date2022-09-15
Marketing CategoryNDA /
Application NumberNDA209360
Labeler NameLa Jolla Pharmaceutical Company
Substance NameANGIOTENSIN II
Active Ingredient Strength1 mg/mL
Pharm ClassesVasoconstriction [PE], Vasoconstrictor [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 68547-005-01

1 VIAL, SINGLE-DOSE in 1 CARTON (68547-005-01) > 1 mL in 1 VIAL, SINGLE-DOSE
Marketing Start Date2022-09-15
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Giapreza" or generic name "Angiotensin Ii"

NDCBrand NameGeneric Name
68547-005Giaprezaangiotensin II
68547-501Giaprezaangiotensin II

Trademark Results [Giapreza]

Mark Image

Registration | Serial
Company
Trademark
Application Date
GIAPREZA
GIAPREZA
87720479 5687263 Live/Registered
La Jolla Pharmaceutical Company
2017-12-14

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.